| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |